Navigation Links
ideaPoint, Inc. Announces Launch of Multi-Sponsor Portal Providing Researchers Opportunity to Request Access to Clinical Data from Five Global Study Sponsors

QUINCY, Mass., Jan. 2, 2014 /PRNewswire/ -- ideaPoint, Inc., a leading provider of partnering and collaboration systems for global enterprises, today announced the availability of a new portal providing a secure system for researchers to request access to anonymized, patient-level clinical trial data provided by sponsor organizations ( Study sponsors who have committed to provide data through the site currently include Boehringer Ingelheim, GlaxoSmithKline, Roche, Sanofi and ViiV Healthcare.

With extensive experience providing online collaboration solutions for global companies, ideaPoint powers the technology behind the new site's secure request and evaluation process. 

As researchers continue to search for treatments and cures to some of society's biggest medical challenges, the opportunity to seek scientific insights that may lead to potential improvements in patient care by conducting further research with clinical trial data has been universally recognized. For the first time, researchers can select studies of interest from multiple sponsors across multiple disease areas and submit a single research proposal through a user-friendly portal. Research proposals to access data are reviewed by an Independent Review Panel who decides whether access should be provided. The panel reviews the proposed science, publication plans, conflicts of interest and the qualifications of the research team. Those involved in this initiative envision transitioning administration and review of future proposals to an independent third party as soon as possible. The site includes easy-to-follow videos and guides on how to use the portal and submit a proposal, available at

In addition to research proposals to request data from clinical trials already listed on the site, researchers can also submit inquiries to some study sponsors to ask about the availability of data from studies not yet listed. Following approval by the Independent Review Panel, researchers are asked to sign a Data Sharing Agreement. A summary of the requirements in this agreement and an agreement template are provided on the site. 

"The design and development of this user-friendly site is an outgrowth of our collaboration and partnering software. Supporting this need was a natural expansion of our work with life science, academic and non-profit organizations, and we are pleased to work with representatives from the sponsor organizations to achieve this milestone," said Scott Shaunessy, CEO and founder of ideaPoint. "Our solution is highly configurable and will allow the functionality to expand as the initiative matures over time."

The portal currently lists multiple studies available from the sponsor organizations. It has been designed with a flexible configuration so that other industry, academic and non-profit sponsors can join and include their studies. Those interested should contact for more information.

ideaPoint and the sponsors who have committed to the site believe this is an important step towards providing greater access to patient-level data in support of biomedical research, and look forward to continued and expanded collaboration within the research community as this initiative evolves over time.

About ideaPoint

ideaPoint, Inc. is an enterprise software provider that helps global Life Science companies accelerate quality decisions on innovation opportunities that have a material impact on their business.

Since its launch in 2008, ideaPoint has delivered software solutions to industry-leading Pharmaceutical, Biotechnology and Medical Device organizations to capture and assess opportunities for collaboration, licensing and acquisition, venture investing, and other partnering models that create growth through new products, new services and new business creation.

Media Inquiries

Please contact Lynn Blenkhorn at: or +1 508-851-0930

SOURCE ideaPoint, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Precision Optics Corporation Announces $1 Million Order for Microprecision™ Based Endoscopes
2. Young Innovations, Inc. Announces Record Sales and EPS for the Quarter Ended March 31, 2012
3. JDRF Announces Research Collaboration with Dexcom, Inc. to Develop "Smart Transmitter" Technology to Accelerate Artificial Pancreas Studies
4. Misonix Announces New Distribution Agreement For Panama
5. University of Maryland BioPark Announces MedImmunes Dr. Bahija Jallal as Newest Member of Board of Directors for UM Health Sciences Research Park
6. Novelos Therapeutics Announces Successful Completion of First Cohort In Lung Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent at UW Carbone Cancer Center
7. Boston Scientific Announces CE Mark and European Launch of Emerge™ PTCA Dilatation Catheter
8. Soligenix Announces Further Progress with ThermoVax™ for Long-Term Vaccine ThermoStability
9. Masimo Announces New Low-Profile Infant and Neonatal Pulse Oximetry Sensors
10. Anthera Announces the Completion of Patient Dosing in Phase 2b PEARL-SC Study
11. STAAR Surgical Announces First Quarter 2012 Results Release Date and Conference Call and Webcast
Post Your Comments:
(Date:11/24/2015)... 24, 2015  Freudenberg Medical has developed specialty tubing for ... of medical facilities. Africa and ... is sparse. Nevertheless, prompt diagnosis is important to treat those ... virus. With the help of a portable mini-lab or "lab ... village in affected areas and perform rapid testing for HIV. ...
(Date:11/24/2015)... November 24, 2015 Edelris announce today ... co-own with Inserm, Poxel, CNRS, UCBL and ENS-Lyon on a ... --> Hepatitis B virus (HBV) infection is ... people chronically infected worldwide, 20 to 40% of them being ... carcinoma. Despite the existence of an effective preventive vaccine, the ...
(Date:11/24/2015)... Ill. , Nov. 24, 2015  Wellness Center USA ... November shipments of its flagship product, Psoria-Light® (PL 1000), to targeted dermatology ... Houston, Minnesota , and North Carolina ... Cleveland , Chicago , and ... --> Revenue for the earlier shipments reported on October ...
Breaking Medicine Technology:
(Date:11/24/2015)... FL (PRWEB) , ... November 24, 2015 , ... In ... a growing epidemic as deaths from prescription opioids in the United States grew 400 ... cocaine. In 2013 alone, opioids were involved in 37 percent of all fatal drug ...
(Date:11/24/2015)... ... , ... Serenity Point Rehabilitation, a holistic treatment center for substance abuse located ... the staff members at their recovery center. The videos highlight some of the various ... the things that make their recovery program so unique. , “Making the decision to ...
(Date:11/24/2015)... ... November 24, 2015 , ... Chiropractic student Katie Benson received ... in Overland Park, Kansas. Benson, a fifth-trimester student in the university’s College of ... on October 16. , “Katie is very excited and greatly appreciative to receive ...
(Date:11/24/2015)... ... November 24, 2015 , ... Autism Speaks, the world’s leading autism science ... social media and the generosity of people around the world. On December 1, supporters ... to give – and share the personal stories behind those gifts. , Just ...
(Date:11/24/2015)... IL (PRWEB) , ... November 24, 2015 , ... ... and engineer of patented products, announces Fragrance by Marcelle, a cosmetic invention which ... The Perfume & Fragrance Manufacturing Market in the US is worth $3 billion ...
Breaking Medicine News(10 mins):